GPCR Stock Summary and Trading Ideas (Structure Therapeutics - American Depositary Shares | NASDAQ:GPCR)

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Structure Therapeutics - American Depositary Shares trades on the NASDAQ stock market under the symbol GPCR.

As of February 20, 2026, GPCR stock price declined to $66.55 with 906,128 million shares trading.

GPCR has a beta of 0.99, meaning it tends to be less sensitive to market movements. GPCR has a correlation of 0.03 to the broad based SPY ETF.

GPCR has a market cap of $4.70 billion. This is considered a Mid Cap stock.

In the last 3 years, GPCR traded as high as $94.90 and as low as $13.22.

The top ETF exchange traded funds that GPCR belongs to (by Net Assets): IBB, FDG, SBIO, EWX, LRNZ.

GPCR has outperformed the market in the last year with a return of +179.0%, while the SPY ETF gained +13.7%. In the last 3 month period, GPCR beat the market returning +82.3%, while SPY returned +4.3%. However, in the most recent 2 weeks GPCR has underperformed the stock market by returning -9.1%, while SPY returned +1.7%.

GPCR support price is $64.89 and resistance is $70.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GPCR shares will trade within this expected range on the day.